Direxion Daily LLY Bear 1X ETF (ELIS)

19.23
+0.34 (1.77%)
Inactive · Last trade price on Apr 10, 2026
Assets$2.40M
Expense Ratio1.01%
PE Ration/a
Shares Out125,001
Dividend (ttm)$1.01
Dividend Yield5.26%
Ex-Dividend DateDec 23, 2025
Payout FrequencyQuarterly
Payout Ration/a
Volume13,961
Open19.04
Previous Close18.90
Day's Range19.04 - 19.27
52-Week Low16.40
52-Week High31.30
Betan/a
Holdings6
Inception DateMar 26, 2025

About ELIS

The Direxion Daily LLY Bear 1X ETF (ELIS) is an exchange-traded fund that mostly invests in health care equity. The fund provides inverse (-1x) exposure, less fees and expenses, to the daily price movement for shares of Eli Lilly and Company stock. ELIS was launched on Mar 26, 2025 and is issued by Direxion.

Asset Class Equity
Category Trading--Inverse Equity
Stock Exchange NASDAQ
Ticker Symbol ELIS
ETF Provider Direxion
Index Tracked Eli Lilly and Co. - Benchmark Price Return

Top Holdings

NameSymbolWeight
Cashn/a98.86%
Eli Lilly And Co Swapn/a2.31%
Eli Lilly And Co Swapn/a1.52%
Eli Lilly And Co Swapn/a0.71%
Eli Lilly And Co Swapn/a-1.19%
Citi Collateraln/a-2.21%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 23, 2025$0.61729Dec 31, 2025
Sep 23, 2025$0.17086Sep 30, 2025
Jun 24, 2025$0.2228Jul 1, 2025
Full Dividend History

Performance

ELIS had a total return of -28.08% in the past year, including dividends. Since the fund's inception, the average annual return has been -19.37%.

News

Direxion Closing Ten ETFs

New York, New York, March 13, 2026 (GLOBE NEWSWIRE) -- Closures Due to Limited Interest Since Launch Due to their inability to attract sufficient investment assets, the Board of Trustees of the Direxi...

4 weeks ago - GlobeNewsWire

Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs

As the largest publicly traded U.S. healthcare enterprise, Eli Lilly & Co. (NYSE:LLY) has historically offered investors a reliable avenue for growth. Indeed, this narrative has been particularly powe...

Other symbols: LLYELIL
6 months ago - Benzinga